PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical and Molecular Hepatology10.3350/cmh.2016.00472016223382-389Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis BHan Ah Lee, Yeon Seok Seo, Seung Woon Park, Sang Jung Park, Tae Hyung Kim, Sang Jun Suh, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun, Soon Ho Umhttp://e-cmh.org/upload/pdf/cmh-2016-0047.pdf, http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2016.0047, http://e-cmh.org/upload/pdf/cmh-2016-0047.pdf
Journal of Viral Hepatitis10.1111/j.1365-2893.2009.01146.x201017116-22Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B*R. G. Gish, T.-T. Chang, C.-L. Lai, R. De Man, A. Gadano, F. Poordad, J. Yang, H. Brett-Smith, R. Tamezhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2893.2009.01146.x
Journal of Viral Hepatitis10.1111/j.1365-2893.2011.01465.x2011187449-457Hepatitis B surface antigen monitoring and management of chronic hepatitis BM. J. Sonneveld, R. Zoutendijk, H. L. A. Janssenhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2893.2011.01465.x, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2893.2011.01465.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2893.2011.01465.x/fullpdf
Journal of Viral Hepatitis10.1111/j.1365-2893.2004.00556.x2004115432-438Sustained response after a 2-year course of lamivudine treatment of hepatitis B e antigen-negative chronic hepatitis BS. K. Fung, F. Wong, M. Hussain, A. S. F. Lokhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2893.2004.00556.x
Clinical Biochemistry10.1016/j.clinbiochem.2011.08.101720114413S319Hepatitis B viral titer in chronic hepatitis patients in BangladeshMd.Mehedi Hasanhttps://api.elsevier.com/content/article/PII:S0009912011024799?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0009912011024799?httpAccept=text/plain
Journal of Viral Hepatitis10.1111/j.1365-2893.2011.01509.x2011192e41-e47Pretreatment HBeAg level and an early decrease in HBeAg level predict virologic response to entecavir treatment for HBeAg-positive chronic hepatitis BJ. H. Kwon, J. W. Jang, S. Lee, J. Lee, K. W. Chung, Y. S. Lee, J. Y. Choihttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2893.2011.01509.x
Journal of Viral Hepatitis10.1046/j.1365-2893.1997.00055.x199744265-272Quantitative assessment of serum hepatitis B e antigen, IgM hepatitis B core antibody and HBV DNA in monitoring the response to treatment in patients with chronic hepatitis BF. Bernard, G. Raymond, B. Willems, J.-P. Villeneuvehttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2893.1997.00055.x
Yearbook of Gastroenterology10.1016/s0739-5930(10)79545-320102010234-235Entecavir treatment for up to 5years in patients with hepatitis B e antigen-positive chronic hepatitis BD.M. Harnoishttps://api.elsevier.com/content/article/PII:S0739593010795453?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0739593010795453?httpAccept=text/plain
Yearbook of Medicine10.1016/s0084-3873(10)79853-920102010473-474Entecavir treatment for up to 5years in patients with hepatitis B e antigen-positive chronic hepatitis BD.M. Harnoishttps://api.elsevier.com/content/article/PII:S0084387310798539?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0084387310798539?httpAccept=text/plain
Journal of Viral Hepatitis10.1111/j.1365-2893.2011.01533.x2011193213-219Response to tenofovir monotherapy in chronic hepatitis B patients with prior suboptimal response to entecavirC. Q. Pan, K.-Q. Hu, A. S. Yu, W. Chen, C. Bunchorntavakul, K. R. Reddyhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2893.2011.01533.x